{"id":240906,"date":"2026-07-15T05:06:34","date_gmt":"2026-07-15T10:06:34","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/hallmarks-and-correlates-of-effective-adoptive-cell-immunotherapy-for-cancer"},"modified":"2026-07-15T05:06:34","modified_gmt":"2026-07-15T10:06:34","slug":"hallmarks-and-correlates-of-effective-adoptive-cell-immunotherapy-for-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/hallmarks-and-correlates-of-effective-adoptive-cell-immunotherapy-for-cancer","title":{"rendered":"Hallmarks and correlates of effective adoptive cell immunotherapy for cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/hallmarks-and-correlates-of-effective-adoptive-cell-immunotherapy-for-cancer.jpg\"><\/a><\/p>\n<p>In this Review, Krishna and colleagues draw on clinical and scientific progress in the past two decades to describe the many factors that influence clinical outcomes during adoptive cell therapy using tumour-infiltrating lymphocytes and TCR-engineered T cell therapies. They explain how T cell-intrinsic factors and tumour-specific factors in patients with advanced cancer challenge or promote the success of adoptive cell transfer (ACT), and outline new approaches in the field of ACT.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In this Review, Krishna and colleagues draw on clinical and scientific progress in the past two decades to describe the many factors that influence clinical outcomes during adoptive cell therapy using tumour-infiltrating lymphocytes and TCR-engineered T cell therapies. They explain how T cell-intrinsic factors and tumour-specific factors in patients with advanced cancer challenge or promote [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-240906","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=240906"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240906\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=240906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=240906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=240906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}